Month: September 2020

SEATTLE—September 3, 2020 —Sana Biotechnology, Inc. (Sana), focused on creating and delivering engineered cells as medicines, announced today two additions to its senior leadership team. Ed Rebar, Ph.D., joins the company as Chief Technology Officer and Terry Fry, M.D. joins as SVP, Head of T Cell Therapeutics. “Ed and Terry are world class scientists who will […]